On May 6, 2011
Wall Street Restless as Allergan Fails to Shake Botox Addiction
The company is a prisoner of its own success — the wrinkle-killer added 10 percent revenue growth in Q2 2011 and newer products have failed to impress.
No tags for this post.
0 Comments